Ardsley Advisory Partners LP Bristol Myers Squibb CO Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $4.62 Million - $5.12 Million	-80,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $4.41 Million - $5.16 Million	80,500 New	80,500 $4.73 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $363,545 - $431,035	-8,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $4.35 Million - $4.81 Million	-97,500 Reduced 91.98%	8,500 $385,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $4.78 Million - $5.7 Million	106,000 New	106,000 $5.06 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.